期刊文献+

免疫细胞在动脉粥样硬化进程中作用的研究进展 被引量:3

Advances in Researchon the Roleof Immune Cells in the Processof Atherosclerosis
原文传递
导出
摘要 动脉粥样硬化斑块破裂是导致急性心肌梗死的重要诱因,严重威胁患者的生命安全。血管内动脉粥样硬化斑块的形成不仅仅与机体脂质代谢异常有关,还与免疫系统异常活化以及炎症因子与血管细胞之间的相互作用密切相关。多项研究表明,机体内多种免疫细胞在动脉粥样硬化过程中扮演着重要角色,提示动脉粥样硬化很可能属于炎症诱发的慢性血管疾病。综述了免疫细胞在动脉粥样硬化进程中作用的研究进展,并对相关免疫治疗策略进行简介,旨在为动脉粥样硬化的机制阐明与临床治疗提供思路与参考。 Rupture of atherosclerotic plaques in arterial blood vessels is a major trigger of acute myocardial infarction,which poses a serious threat to the patient's life.The formation of atherosclerotic plaques in blood vessels is not only associated with abnormal lipid metabolism in the body,but also closely related to abnormal activation of the immune system and the interaction between inflammatory factors and vascular cells.Several studies have shown that various immune cells in the body play important roles in the process of atherosclerosis,suggesting that atherosclerosis is likely to be a chronic vascular disease induced by inflammation.This article reviews the advances in research on the role of immune cells in the progression of atherosclerosis,and introduces the relevant immunotherapies,aiming to provide ideas and references for mechanisms elucidation and clinical treatment of atherosclerosis.
作者 李婧玉 李琦 陈畅 LI Jingyu;LI Qi;CHEN Chang(Department of Pharmacology,College of Pharmacy,Harbin Medical University,Harbin 150086,China;The Biotherapy Center,Harbin Medical University Cancer Hospital,Harbin 150086,China)
出处 《药学进展》 CAS 2023年第7期542-550,共9页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金(No.81970382)。
关键词 动脉粥样硬化 免疫细胞 炎症 免疫治疗 atherosclerosis immune cell infammation immune therapy
  • 相关文献

参考文献6

二级参考文献43

  • 1陈羽斐,沈伟,施海明.巨噬细胞免疫代谢与动脉粥样硬化的研究进展[J].中国动脉硬化杂志,2020,0(1):74-80. 被引量:22
  • 2李大主,Sharma Ranjit,曾秋棠,田园,冯义柏,王祥,曹林生,郭和平,王敏.雷帕霉素对人树突状细胞功能的影响[J].中国介入心脏病学杂志,2004,12(4):244-246. 被引量:8
  • 3姚康,葛均波,孙爱军,洪晓武,施鸿毓,黄榕翀,贾庆哲,王克强,钟翠平,曹雪涛,邹云增.高糖对人单核细胞源树突状细胞分化成熟和免疫功能的影响及其机制研究[J].中华心血管病杂志,2006,34(1):60-64. 被引量:18
  • 4吕永恒,李志樑,刘映峰,吴宏超,叶文胜,严全能,付强.冠心病患者树突状细胞的功能及依那普利干预效应[J].高血压杂志,2006,14(6):442-445. 被引量:6
  • 5Mahmoudi M, Curzen N, Gallagher PJ, et al. A therogenesis: the role of inflammation and infection [J]. Histopathology, 2007,50(5):535 -546.
  • 6Ohashi R, Mu H, Yao Q, et al. A therosclerosis:immunopathogenesis and immunotherapy[J]. Med Sci Monit, 2004,10(11) :255-260.
  • 7Yilmaz A, Lochno M, Traeg F, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques[J]. Atherosclerosis, 2004,176 ( 1 ) :101-110.
  • 8Wu Q, Xia D, Carlsen S, et al. Adenovirus-mediated transgene- engineered dendritic cell vaccine of cancer[J]. Curr Gene Ther, 2005,5(2) :237-247.
  • 9Beckman EM,Brenner MB. MHC class I-like,class II-like and CDI molecules: distinct roles in immunity [J]. Immunol Today, 1995,16(7) :349-352.
  • 10CAO X, Zhang W, He L, et al. lymphotactin gene modified bone marrow dendritic cells act as more potent adjuvants for peplide delivery to induce specific antitumor immunity[J]. J Immunol, 1998,161(11) :6238-6244.

共引文献53

同被引文献20

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部